hydroxychloroquine has been researched along with Hepatitis B, Chronic in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| M'bodj, K | 1 |
| Abid, H | 1 |
| Adil, N | 1 |
| Abkari, ME | 1 |
| Aqodad, N | 1 |
1 review available for hydroxychloroquine and Hepatitis B, Chronic
| Article | Year |
|---|---|
What would be the impact of COVID-19 on liver function of a patient with chronic hepatitis B? About a case and literature review.
Topics: Adult; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Hepatitis B, Chronic; Hosp | 2021 |